
Vertex Pharmaceuticals ownership: holders and insider trading
$538.60−0.74%Close 13 Nov 2026
As filed, its directors and officers own 0.2% of the shares (proxy statement, 16 Mar 2026); 1,741 institutional managers reported holding 95.5% at 30 Jun 2026. Over the last twelve months, insiders sold $132.1M of shares on the open market, $132.1M of it under 10b5-1 plans set in advance, and bought none.
From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.
Largest holders
| Holder | Type | Shares | Of the company | Source | As of |
|---|
| Capital World Investors | Holder | 50.3M | 19.86%* | Form 13F | 30 Jun 2026 |
|---|
| BlackRock, Inc. | Holder | 24.1M | 9.51%* | Form 13F | 30 Jun 2026 |
|---|
| The Vanguard Group | Holder | 24.1M | 9.51%* | Form 13F | 30 Jun 2026 |
|---|
| Vanguard Capital Management | Holder | 19.0M | 7.49% | Schedule 13G | 31 Mar 2026 |
|---|
| Capital Research Global Investors | Holder | 17.8M | 7% | Schedule 13G | 30 Sep 2026 |
|---|
| State Street | Institution | 11.9M | 4.68%* | Form 13F | 30 Jun 2026 |
|---|
| Invesco | Institution | 8.0M | 3.17%* | Form 13F | 30 Jun 2026 |
|---|
| JPMorgan Chase | Institution | 6.5M | 2.57%* | Form 13F | 30 Jun 2026 |
|---|
| Geode Capital Management | Institution | 6.0M | 2.37%* | Form 13F | 30 Jun 2026 |
|---|
| Loomis Sayles & Co L P | Institution | 3.9M | 1.55%* | Form 13F | 30 Jun 2026 |
|---|
| UBS | Institution | 3.8M | 1.50%* | Form 13F | 30 Jun 2026 |
|---|
| Franklin Templeton | Institution | 3.3M | 1.32%* | Form 13F | 30 Jun 2026 |
|---|
| Wellington Management | Institution | 3.2M | 1.28%* | Form 13F | 30 Jun 2026 |
|---|
| Morgan Stanley | Institution | 3.2M | 1.28%* | Form 13F | 30 Jun 2026 |
|---|
| Bank of America | Institution | 3.0M | 1.20%* | Form 13F | 30 Jun 2026 |
|---|
| Alliancebernstein L.p. | Institution | 3.0M | 1.19%* | Form 13F | 30 Jun 2026 |
|---|
| Jennison Associates LLC | Institution | 3.0M | 1.18%* | Form 13F | 30 Jun 2026 |
|---|
| Norges Bank | Institution | 3.0M | 1.17%* | Form 13F | 30 Jun 2026 |
|---|
| Ameriprise | Institution | 2.6M | 1.03%* | Form 13F | 30 Jun 2026 |
|---|
| Northern Trust | Institution | 2.5M | 0.98%* | Form 13F | 30 Jun 2026 |
|---|
Insider transactions latest 25
Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.
VRTX in the terminal
Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.